HomeKPTI • NASDAQ
add
Karyopharm Therapeutics Inc
Previous close
$0.72
Day range
$0.67 - $0.76
Year range
$0.58 - $1.95
Market cap
90.18M USD
Avg Volume
1.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 38.78M | 7.70% |
Operating expense | 27.63M | -10.30% |
Net income | -32.07M | 7.05% |
Net profit margin | -82.70 | 13.70% |
Earnings per share | -0.26 | 13.33% |
EBITDA | -26.20M | 15.97% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 133.53M | -35.90% |
Total assets | 189.48M | -29.81% |
Total liabilities | 349.12M | -5.73% |
Total equity | -159.65M | — |
Shares outstanding | 125.31M | — |
Price to book | -0.56 | — |
Return on assets | -32.57% | — |
Return on capital | -53.62% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -32.07M | 7.05% |
Cash from operations | -19.45M | 34.12% |
Cash from investing | 7.47M | 197.25% |
Cash from financing | 0.00 | — |
Net change in cash | -11.94M | 67.95% |
Free cash flow | -7.93M | 47.88% |
About
Founded
2008
Headquarters
Website
Employees
325
